Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
130.7 USD | -0.95% | -7.42% | -27.47% |
Apr. 17 | BeiGene to Award Shares Worth $15 Million to 11 Directors | MT |
Apr. 11 | Western Drugmakers Seeking Alternative Suppliers as US Looks to Restrict Chinese Biotech | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.47% | 13.79B | |
-2.73% | 102B | |
+1.96% | 96.07B | |
-1.86% | 21.66B | |
-17.92% | 20.77B | |
-6.91% | 18.53B | |
-40.31% | 16.91B | |
+0.20% | 13.33B | |
+20.04% | 10.94B | |
-22.12% | 8.57B |
- Stock Market
- Equities
- BGNE Stock
- News BeiGene, Ltd.
- Morgan Stanley Adjusts BeiGene's Price Target to $338 from $330, Keeps Overweight Rating